Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Long Term Debt Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual long term debt in 2023 was 3.92 Million CNY , down -82.02% from previous year.
Genor Biopharma Holdings Limited's latest quarterly long term debt in 2024 Q2 was - CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported annual long term debt of 21.82 Million CNY in 2022, up 8.53% from previous year.
Genor Biopharma Holdings Limited reported annual long term debt of 20.1 Million CNY in 2021, up 25.56% from previous year.
Genor Biopharma Holdings Limited reported quarterly long term debt of - CNY for 2024 Q2, down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported quarterly long term debt of 23.69 Million CNY for 2023 Q1, up 8.56% from previous quarter.

Annual Long Term Debt Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Long Term Debt of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Long Term Debt	Long Term Debt Growth
2023	3.92 Million CNY	-82.02%
2022	21.82 Million CNY	8.53%
2021	20.1 Million CNY	25.56%
2020	16.01 Million CNY	-45.44%
2019	29.35 Million CNY	-18.0%
2018	35.79 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- CNY	0.0%
2024 Q2	- CNY	0.0%
2023 Q1	23.69 Million CNY	8.56%
2023 FY	3.92 Million CNY	-82.02%
2023 Q4	3.92 Million CNY	0.0%
2023 Q3	3.92 Million CNY	-83.44%
2023 Q2	23.69 Million CNY	0.0%
2022 Q2	40.02 Million CNY	0.0%
2022 Q1	40.02 Million CNY	99.07%
2022 Q4	21.82 Million CNY	0.0%
2022 FY	21.82 Million CNY	8.53%
2022 Q3	21.82 Million CNY	-45.48%
2021 FY	20.1 Million CNY	25.56%
2021 Q1	17.37 Million CNY	8.52%
2021 Q4	20.1 Million CNY	0.0%
2021 Q3	20.1 Million CNY	15.7%
2021 Q2	17.37 Million CNY	0.0%
2020 FY	16.01 Million CNY	-45.44%
2020 Q1	26.78 Million CNY	0.0%
2020 Q2	- CNY	-100.0%
2020 Q4	16.01 Million CNY	0.0%
2020 Q3	16.01 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 FY	29.35 Million CNY	-18.0%
2018 FY	35.79 Million CNY	0.0%

Peer Long Term Debt Comparison of Genor Biopharma Holdings Limited

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	87.181%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	99.908%